miRNAs as potential game-changers in melanoma: A comprehensive review.

[1]  Mohammed H Rashed,et al.  The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways. , 2023, Pathology, research and practice.

[2]  Heba Moustafa,et al.  miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. , 2023, Pathology, research and practice.

[3]  Ahmed E. Elesawy,et al.  The role of miRNAs in liver diseases: Potential therapeutic and clinical applications. , 2023, Pathology, research and practice.

[4]  A. Abulsoud,et al.  miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways. , 2023, Pathology, research and practice.

[5]  Amr M. Yehia,et al.  Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways. , 2023, Pathology, research and practice.

[6]  K. Chen,et al.  Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation , 2023, Pigment cell & melanoma research.

[7]  A. El-Husseiny,et al.  miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review. , 2023, Pathology, research and practice.

[8]  Sylvia F. Fawzi,et al.  The role of miRNAs in insulin resistance and diabetic macrovascular complications - A review. , 2023, International journal of biological macromolecules.

[9]  M. Elkady,et al.  miRNAs as cornerstones in adipogenesis and obesity. , 2023, Life sciences.

[10]  L. Florea,et al.  Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies , 2022, International journal of molecular sciences.

[11]  Yirong Li,et al.  Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment , 2022, Cancers.

[12]  P. Niedźwiedzka-Rystwej,et al.  Role of miRNA in Melanoma Development and Progression , 2022, International journal of molecular sciences.

[13]  H. M. El-Husseiny,et al.  miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers. , 2022, Life sciences.

[14]  M. Eldeib,et al.  miRNAs as cornerstones in diabetic microvascular complications. , 2022, Molecular genetics and metabolism.

[15]  M. Abdel-Daim,et al.  Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions , 2022, Biomedicine & Pharmacotherapy.

[16]  Ahmed S. Doghish,et al.  The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[17]  M. Sobhy,et al.  Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase. , 2022, Pathology, research and practice.

[18]  Ahmed S. Doghish,et al.  Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review. , 2022, International journal of biological macromolecules.

[19]  J. Li,et al.  Extracellular vesicles microRNA-592 of melanoma stem cells promotes metastasis through activation of MAPK/ERK signaling pathway by targeting PTPN7 in non-stemness melanoma cells , 2022, Cell Death Discovery.

[20]  T. Noviello,et al.  A novel microRNA signature for the detection of melanoma by liquid biopsy , 2022, Journal of Translational Medicine.

[21]  E. Chowdhury,et al.  Evolving therapeutic proteins to precisely kill cancer cells. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[22]  T. Al-Warhi,et al.  Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies , 2022, Pharmaceuticals.

[23]  S. Salem,et al.  Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: Synthesis, characterization, antimicrobial, and anticancer activities , 2022, Journal of Drug Delivery Science and Technology.

[24]  Jianyu Wang,et al.  Melanoma stem cells promote metastasis via exosomal miR-1268a inactivation of autophagy , 2022, Biological Research.

[25]  M. Neagu,et al.  Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating , 2022, Journal of personalized medicine.

[26]  Ahmed S. Doghish,et al.  Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review. , 2022, Life sciences.

[27]  S. Salem,et al.  Synthesis of Silver Nanocomposite Based on Carboxymethyl Cellulose: Antibacterial, Antifungal and Anticancer Activities , 2022, Polymers.

[28]  M. Negrini,et al.  Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy , 2022, Cancers.

[29]  Ahmed S. Doghish,et al.  A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[30]  W. Elkhatib,et al.  Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt , 2022, PloS one.

[31]  Walaa A. El-Dakroury,et al.  Design, Characterization and In Vivo Performance of Solid Lipid Nanoparticles (SLNs)-Loaded Mucoadhesive Buccal Tablets for Efficient Delivery of Lornoxicam in Experimental Inflammation. , 2022, International journal of pharmaceutics.

[32]  M. Ratajewski,et al.  Targeting EGFR in melanoma - The sea of possibilities to overcome drug resistance. , 2022, Biochimica et biophysica acta. Reviews on cancer.

[33]  A. A. Ahmed,et al.  miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. , 2022, International journal of biological macromolecules.

[34]  H. M. El-Husseiny,et al.  Smart/stimuli-responsive hydrogels: State-of-the-art platforms for bone tissue engineering , 2022, Applied Materials Today.

[35]  W. El‐Sayed,et al.  Discovery of pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations , 2022, RSC advances.

[36]  M. Ma,et al.  The Role and Mechanism of microRNA-1224 in Human Cancer , 2022, Frontiers in Oncology.

[37]  Zhiwei Sun,et al.  Low-metastatic melanoma cells acquire enhanced metastatic capability via exosomal transfer of miR-199a-1-5p from highly metastatic melanoma cells , 2022, Cell death discovery.

[38]  Nancy A. Huang,et al.  Current Trends in Circulating Biomarkers for Melanoma Detection , 2022, Frontiers in Medicine.

[39]  Al-aliaa M. Sallam,et al.  miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. , 2022, Pathology, research and practice.

[40]  Jianyu Wang,et al.  Exosomal microRNA-4535 of Melanoma Stem Cells Promotes Metastasis by Inhibiting Autophagy Pathway , 2022, Stem Cell Reviews and Reports.

[41]  Xiaobo Zhang,et al.  The role of EphA7 in different tumors , 2022, Clinical and Translational Oncology.

[42]  Ying Wang,et al.  MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5 , 2021, Computational and mathematical methods in medicine.

[43]  A. Ismail,et al.  A review of the biological role of miRNAs in prostate cancer suppression and progression. , 2021, International journal of biological macromolecules.

[44]  M. Al-Azab,et al.  Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study , 2021, Frontiers in Immunology.

[45]  C. Pichon,et al.  miRNA Delivery by Nanosystems: State of the Art and Perspectives , 2021, Pharmaceutics.

[46]  Prashanth Rawla,et al.  Epidemiology of Melanoma , 2021, Medical sciences.

[47]  W. Placzek,et al.  The multiple mechanisms of MCL1 in the regulation of cell fate , 2021, Communications biology.

[48]  W. E. El Rouby,et al.  Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer , 2021, RSC advances.

[49]  M. Kogo,et al.  Progression of melanoma is suppressed by targeting all transforming growth factor-β isoforms with an Fc chimeric receptor , 2021, Oncology reports.

[50]  M. Taheri,et al.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets , 2021, Frontiers in Oncology.

[51]  W. Elkhatib,et al.  Clinical characteristics of Egyptian male patients with COVID‐19 acute respiratory distress syndrome , 2021, PloS one.

[52]  S. Meierjohann,et al.  NRF2 Enables EGFR Signaling in Melanoma Cells , 2021, International journal of molecular sciences.

[53]  Yi Tian,et al.  MicroRNA-27b inhibits the development of melanoma by targeting MYC , 2021, Oncology letters.

[54]  Xien Feng.  miR-548b Suppresses Melanoma Cell Growth, Migration, and Invasion by Negatively Regulating Its Target Gene HMGB1. , 2021, Cancer biotherapy & radiopharmaceuticals.

[55]  M. Elshafey,et al.  MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8 , 2021, Saudi journal of biological sciences.

[56]  A. Amin,et al.  Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome. , 2021, Canadian journal of diabetes.

[57]  Hao Guo,et al.  Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma , 2021, Human Cell.

[58]  E. M. Gedawy,et al.  Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers , 2021, Journal of enzyme inhibition and medicinal chemistry.

[59]  L. Heinzerling,et al.  Current Melanoma Treatments: Where Do We Stand? , 2021, Cancers.

[60]  Yaling Liu,et al.  MicroRNA-633 enhances melanoma cell proliferation and migration by suppressing KAI1 , 2020, Oncology letters.

[61]  Wenli Shi,et al.  miR-18a-5p promotes melanoma cell proliferation and inhibits apoptosis and autophagy by targeting EPHA7 signaling , 2020, Molecular medicine reports.

[62]  Wen-Jie Zhou,et al.  NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma , 2020, Aging.

[63]  Y. Kandil,et al.  Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. , 2020, Life sciences.

[64]  Yujiao Xu,et al.  miR-942-5p promotes the proliferation and invasion of human melanoma cells by targeting DKK3 , 2020, Journal of receptor and signal transduction research.

[65]  W. Wei,et al.  MicroRNA-145 suppresses uveal melanoma angiogenesis and growth by targeting neuroblastoma RAS viral oncogene homolog and vascular endothelial growth factor. , 2020, Chinese medical journal.

[66]  P. Ascierto,et al.  MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors , 2020, International journal of molecular sciences.

[67]  B. Elsadek,et al.  Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase , 2020, Steroids.

[68]  B. Elsadek,et al.  Androgen/androgen receptor affects gentamicin-induced nephrotoxicity through regulation of megalin expression. , 2020, Life sciences.

[69]  W. Elkhatib,et al.  Effect of scopoletin on phagocytic activity of U937-derived human macrophages: Insights from transcriptomic analysis. , 2020, Genomics.

[70]  Yan Yang,et al.  miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2 , 2020, Molecular therapy oncolytics.

[71]  G. Dittmar,et al.  Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles , 2020, Cancers.

[72]  M. Neagu,et al.  miRNAs in the Diagnosis and Prognosis of Skin Cancer , 2020, Frontiers in Cell and Developmental Biology.

[73]  Yanhua Yu,et al.  MicroRNA-1246 Promotes Melanoma Progression Through Targeting FOXA2 , 2020, OncoTargets and therapy.

[74]  S. Tommasi,et al.  miRNAs as Key Players in the Management of Cutaneous Melanoma , 2020, Cells.

[75]  E. Caputo,et al.  The miRNAs Role in Melanoma and in Its Resistance to Therapy , 2020, International journal of molecular sciences.

[76]  Xiaobin Han,et al.  MicroRNA-127 Inhibits the Progression of Melanoma by Downregulating Delta-Like Homologue 1 , 2020, BioMed research international.

[77]  Yuchong Wang,et al.  Identification of key microRNAs of plasma extracellular vesicles and their diagnostic and prognostic significance in melanoma , 2020, Open medicine.

[78]  Y. Mahran,et al.  Growth hormone modulates the inflammatory and apoptotic pathways incorporated in fluorouracil-induced oral mucositis in rats , 2020 .

[79]  I. Stanganelli,et al.  The association between pesticide use and cutaneous melanoma: a systematic review and meta‐analysis , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[80]  S. Fogli,et al.  Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma , 2019, Expert review of molecular diagnostics.

[81]  Lei Qu,et al.  miR-652 Promotes Proliferation and Migration of Uveal Melanoma Cells by Targeting HOXA9 , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[82]  Yanchang Li,et al.  MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R , 2019, Cell cycle.

[83]  Huan Sun,et al.  MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1. , 2019, European review for medical and pharmacological sciences.

[84]  Yan Xu,et al.  miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression. , 2019, Gene.

[85]  A. Carè,et al.  miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A , 2019, Journal of experimental & clinical cancer research : CR.

[86]  Jian-Qin Wang,et al.  MicroRNA‐329 upregulation impairs the HMGB2/β‐catenin pathway and regulates cell biological behaviors in melanoma , 2019, Journal of cellular physiology.

[87]  L. Shi,et al.  MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. , 2019, European review for medical and pharmacological sciences.

[88]  O. Mansour,et al.  Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients , 2019, Diabetes, metabolic syndrome and obesity : targets and therapy.

[89]  D. Hu,et al.  miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1 , 2019, Cancer management and research.

[90]  C. Blank,et al.  The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment , 2019, Clinical Cancer Research.

[91]  Dandan Liu,et al.  Long non-coding RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma progression through targeting miR-1224-5p. , 2018, Experimental and therapeutic medicine.

[92]  Atef A Bassyouni,et al.  Plasma endoglin in Type2 diabetic patients with nephropathy. , 2019, Diabetes & metabolic syndrome.

[93]  Wei Lin,et al.  Downregulation of the expression of the lncRNA MIAT inhibits melanoma migration and invasion through the PI3K/AKT signaling pathway. , 2019, Cancer biomarkers : section A of Disease markers.

[94]  Matteo Bottai,et al.  Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma , 2018, PloS one.

[95]  T. Dragovich,et al.  Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma , 2018, OncoTargets and therapy.

[96]  Q. Jiang,et al.  miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47. , 2018, Medecine sciences : M/S.

[97]  L. Mariani,et al.  Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma , 2018, The Journal of clinical investigation.

[98]  R. Jayaraj,et al.  Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients , 2018, Molecular Diagnosis & Therapy.

[99]  L. Fattore,et al.  Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma , 2018, Cell Death & Differentiation.

[100]  Carola Berking,et al.  Melanoma , 2018, The Lancet.

[101]  Ying Zheng,et al.  The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway. , 2018, Biochemical and biophysical research communications.

[102]  Juan Zhang,et al.  Matrine exerts inhibitory effects in melanoma through the regulation of miR-19b-3p/PTEN. , 2018, International journal of oncology.

[103]  Yong Zhu,et al.  MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1) , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[104]  P. Soares,et al.  Melanoma treatment in review , 2018, ImmunoTargets and therapy.

[105]  Jie Zhang,et al.  MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells , 2018, BMC Cancer.

[106]  C. Croce,et al.  Friend or Foe: MicroRNAs in the p53 network. , 2018, Cancer letters.

[107]  Quan Shi,et al.  MicroRNA-342 prohibits proliferation and invasion of melanoma cells by directly targeting Zinc-finger E-box binding homeobox 1. , 2018, Oncology research.

[108]  R. Van Laar,et al.  Development and validation of a plasma-based melanoma biomarker suitable for clinical use , 2018, British Journal of Cancer.

[109]  Jie Yang,et al.  MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4 , 2017, Oncology letters.

[110]  Xu-e Chen,et al.  miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN. , 2017, Oncology reports.

[111]  L. Alonso,et al.  miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma. , 2018, Cancer research.

[112]  J. Paoli,et al.  Clinical assessment of skin phototypes: watch your words! , 2017, European Journal of Dermatology.

[113]  Y. Sher,et al.  ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT , 2017, Scientific Reports.

[114]  Xiaojing Li,et al.  Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial–mesenchymal transition by targetting PMEL through the Wnt signaling pathway , 2017, Bioscience reports.

[115]  M. Bosenberg,et al.  Melanocytic nevi and melanoma: unraveling a complex relationship , 2017, Oncogene.

[116]  K. Flaherty,et al.  MicroRNA‐125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway , 2017, Pigment cell & melanoma research.

[117]  Dingwei Zhang,et al.  MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[118]  Nanze Yu,et al.  Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway , 2017, Oncology reports.

[119]  Katie Bentley,et al.  The temporal basis of angiogenesis , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[120]  Xuhua Mao,et al.  MicroRNA‐21 regulates the ERK/NF‐κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN , 2017, Molecular carcinogenesis.

[121]  Ahmed S. Doghish,et al.  Matrix metalloproteinase (MMP)-2 -1306 C > T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients , 2016 .

[122]  C. Tu,et al.  miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation. , 2016, Oncology reports.

[123]  G. Merlino,et al.  Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy , 2016, PloS one.

[124]  Dingwei Zhang,et al.  Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway , 2016, International journal of molecular sciences.

[125]  C. Croce,et al.  miR-579-3p controls melanoma progression and resistance to target therapy , 2016, Proceedings of the National Academy of Sciences.

[126]  Shangqi Yang,et al.  MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[127]  Jun Li,et al.  miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways , 2016, Oncotarget.

[128]  Paola Frati,et al.  Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b , 2015, Oncotarget.

[129]  M. Lacroix-Triki,et al.  Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma. , 2016, Acta dermato-venereologica.

[130]  Lei Sun,et al.  MicroRNA‐454 functions as an oncogene by regulating PTEN in uveal melanoma , 2015, FEBS letters.

[131]  Yu Zhang,et al.  siRNA Versus miRNA as Therapeutics for Gene Silencing , 2015, Molecular therapy. Nucleic acids.

[132]  K. Flaherty,et al.  MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603 , 2015, Clinical Epigenetics.

[133]  C. Tu,et al.  MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells. , 2015, International journal of clinical and experimental pathology.

[134]  Lei Sun,et al.  MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression , 2015, PloS one.

[135]  P. Pollock,et al.  miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma , 2015, Oncotarget.

[136]  J. Schneider,et al.  Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? , 2015, Oncotarget.

[137]  D. Schadendorf,et al.  miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy , 2014, Oncotarget.

[138]  Jing Wang,et al.  Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance , 2014, Genes & diseases.

[139]  V. Spiegelman,et al.  MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma. , 2014, Archives of biochemistry and biophysics.

[140]  Alfredo Hidalgo-Miranda,et al.  miRNA biogenesis: Biological impact in the development of cancer , 2014, Cancer biology & therapy.

[141]  Hoong-Chien Lee,et al.  miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2 , 2014, Oncotarget.

[142]  K. Chu,et al.  MiRNA as potential biomarkers and therapeutic targets for gastric cancer. , 2014, World journal of gastroenterology.

[143]  Li Yang,et al.  MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate‐1 , 2014, Chinese medical journal.

[144]  Michael R Green,et al.  miR-146a promotes the initiation and progression of melanoma by activating Notch signaling , 2014, eLife.

[145]  Lin Fang,et al.  MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer , 2013, Cancer Cell International.

[146]  H. Kaufman,et al.  Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions , 2013, American Journal of Clinical Dermatology.

[147]  S. Majid,et al.  The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression , 2013, Journal of the National Cancer Institute.

[148]  S. Tavazoie,et al.  Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis , 2012, Cell.

[149]  M. Tetzlaff,et al.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. , 2012, The American journal of pathology.

[150]  Ping Li,et al.  MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway. , 2012, Oncology reports.

[151]  A. Baker,et al.  Serum microRNAs as biomarkers for recurrence in melanoma , 2012, Journal of Translational Medicine.

[152]  D. Hu,et al.  Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2 , 2012, PloS one.

[153]  T. Gambichler,et al.  Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi , 2012, Cell and Tissue Research.

[154]  Y. Komiya,et al.  Wnt signal transduction pathways , 2008, Organogenesis.

[155]  Gerard C Blobe,et al.  Role of transforming growth factor-beta superfamily signaling pathways in human disease. , 2008, Biochimica et biophysica acta.

[156]  Eugene Berezikov,et al.  Mammalian mirtron genes. , 2007, Molecular cell.

[157]  P. Guldberg,et al.  The genome and epigenome of malignant melanoma , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[158]  S. Cohen,et al.  microRNA functions. , 2007, Annual review of cell and developmental biology.

[159]  B. Davidson,et al.  RNA polymerase III transcribes human microRNAs , 2006, Nature Structural &Molecular Biology.

[160]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[161]  Y. Rycke,et al.  UVA radiation is highly mutagenic in cells that are unable to repair 7,8-dihydro-8-oxoguanine in Saccharomyces cerevisiae. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[162]  R. Shiekhattar,et al.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing , 2005, Nature.

[163]  Hanah Margalit,et al.  Clustering and conservation patterns of human microRNAs , 2005, Nucleic acids research.

[164]  B. Cullen,et al.  Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. , 2004, RNA.

[165]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[166]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[167]  G. Robertson,et al.  Loss of PTEN promotes tumor development in malignant melanoma. , 2003, Cancer research.

[168]  D. Court,et al.  Crystallographic and modeling studies of RNase III suggest a mechanism for double-stranded RNA cleavage. , 2001, Structure.